Unknown

Dataset Information

0

Characterisation of a solvent-tolerant haloarchaeal (R)-selective transaminase isolated from a Triassic period salt mine.


ABSTRACT: Transaminase enzymes (TAms) are becoming increasingly valuable in the chemist's toolbox as a biocatalytic route to chiral amines. Despite high profile successes, the lack of (R)-selective TAms and robustness under harsh industrial conditions continue to prove problematic. Herein, we report the isolation of the first haloarchaeal TAm (BC61-TAm) to be characterised for the purposes of pharmaceutical biocatalysis. BC61-TAm is an (R)-selective enzyme, cloned from an extremely halophilic archaeon, isolated from a Triassic period salt mine. Produced using a Haloferax volcanii-based expression model, the resulting protein displays a classic halophilic activity profile, as well as thermotolerance (optimum 50 °C) and organic solvent tolerance. Molecular modelling predicts the putative active site residues of haloarchaeal TAms, with molecular dynamics simulations providing insights on the basis of BC61-TAm's organic solvent tolerance. These results represent an exciting advance in the study of transaminases from extremophiles, providing a possible scaffold for future discovery of biocatalytic enzymes with robust properties.

SUBMITTER: Kelly SA 

PROVIDER: S-EPMC6597733 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterisation of a solvent-tolerant haloarchaeal (R)-selective transaminase isolated from a Triassic period salt mine.

Kelly Stephen A SA   Magill Damian J DJ   Megaw Julianne J   Skvortsov Timofey T   Allers Thorsten T   McGrath John W JW   Allen Christopher C R CCR   Moody Thomas S TS   Gilmore Brendan F BF  

Applied microbiology and biotechnology 20190523 14


Transaminase enzymes (TAms) are becoming increasingly valuable in the chemist's toolbox as a biocatalytic route to chiral amines. Despite high profile successes, the lack of (R)-selective TAms and robustness under harsh industrial conditions continue to prove problematic. Herein, we report the isolation of the first haloarchaeal TAm (BC61-TAm) to be characterised for the purposes of pharmaceutical biocatalysis. BC61-TAm is an (R)-selective enzyme, cloned from an extremely halophilic archaeon, is  ...[more]

Similar Datasets

| PRJEB41203 | ENA
| S-EPMC6219536 | biostudies-literature
| S-EPMC3443139 | biostudies-literature
| S-EPMC10473253 | biostudies-literature
| S-EPMC3929378 | biostudies-other
| S-EPMC6042804 | biostudies-other
| S-EPMC6937235 | biostudies-literature
2017-06-04 | GSE86321 | GEO
| S-EPMC5041007 | biostudies-literature
| S-EPMC6635938 | biostudies-literature